Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × pamiparib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 82 Cisplatin 65 Capecitabine 34 Oxaliplatin 31 durvalumab 29 pembrolizumab 24 Fluorouracil 23 Leucovorin 22 S 1 (combination) 16 lenvatinib 12 Nivolumab 12 Irinotecan 12 tremelimumab 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 9 Injections 7 Immune Checkpoint Inhibitors 7 Docetaxel 7 apatinib 6 Trastuzumab 6 titanium silicide 5 surufatinib 5 irinotecan sucrosofate 5 camrelizumab 5 Folfox protocol 5 Drug Therapy 5 Carboplatin 5 Blood Specimen Collection 5 Albumin-Bound Paclitaxel 5 zanidatamab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04796454 2022-06-01

PAMICC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡